Telemus Capital LLC lowered its stake in Express Scripts Holding Co (NASDAQ:ESRX) by 11.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 4,083 shares of the company’s stock after selling 545 shares during the quarter. Telemus Capital LLC’s holdings in Express Scripts were worth $388,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the business. Landaas & Co. WI ADV bought a new stake in Express Scripts during the 2nd quarter valued at $102,000. Kaizen Advisory LLC raised its holdings in Express Scripts by 147.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock valued at $104,000 after buying an additional 800 shares during the last quarter. Adviser Investments LLC raised its holdings in Express Scripts by 321.9% during the 2nd quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock valued at $114,000 after buying an additional 1,130 shares during the last quarter. TRUE Private Wealth Advisors bought a new stake in Express Scripts during the 3rd quarter valued at $115,000. Finally, Sun Life Financial INC raised its holdings in Express Scripts by 758.8% during the 2nd quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock valued at $117,000 after buying an additional 1,343 shares during the last quarter. Hedge funds and other institutional investors own 84.76% of the company’s stock.
Shares of NASDAQ ESRX opened at $95.41 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.71 and a quick ratio of 0.59. Express Scripts Holding Co has a 12 month low of $58.58 and a 12 month high of $97.22. The firm has a market capitalization of $53.40 billion, a price-to-earnings ratio of 13.44, a P/E/G ratio of 1.20 and a beta of 1.01.
Several brokerages have recently commented on ESRX. BidaskClub downgraded shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Tuesday, July 10th. Zacks Investment Research downgraded shares of Express Scripts from a “hold” rating to a “sell” rating in a research note on Monday, July 23rd. William Blair raised shares of Express Scripts from a “market perform” rating to an “outperform” rating in a research note on Wednesday, August 1st. Robert W. Baird lowered Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 price target for the company. in a research report on Friday, July 20th. Finally, Royal Bank of Canada upped their price target on Express Scripts to $94.00 and gave the company an “outperform” rating in a research report on Monday, August 27th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Express Scripts presently has a consensus rating of “Hold” and a consensus target price of $86.36.
In related news, insider Christine Houston sold 12,898 shares of the stock in a transaction dated Friday, August 10th. The shares were sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the transaction, the insider now directly owns 110,908 shares of the company’s stock, valued at $9,427,180. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.79% of the stock is owned by corporate insiders.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Read More: Short Selling
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.